Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to sheep
- PMID: 9918330
- PMCID: PMC1189511
Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to sheep
Abstract
The pharmacokinetics of a 2:1 ampicillin-sulbactam combination were studied in 6 sheep, after intravenous and intramuscular injection at a single dose rate of 20 mg/kg body weight (13.33 mg/kg of sodium ampicillin and 6.67 mg/kg of sodium sulbactam). The drugs were distributed according to an open 2-compartment model after intravenous administration and a one-compartment model with first order absorption after intramuscular administration. The apparent volumes of distribution calculated by the area method of ampicillin and sulbactam were 0.32+/-0.06 L/kg and 0.42+/-0.04 L/kg, respectively and the total body clearances were 0.69+/-0.07 and 0.38+/-0.03 L/kg x h, respectively. The elimination half-lives of ampicillin after intravenous and intramuscular administration were 0.32+/-0.05 h and 0.75+/-0.27 h, respectively, whereas for sulbactam the half-lives were 0.74+/-0.10 h and 0.89+/-0.16 h, respectively. The bioavailability after intramuscular injection was high and similar in both drugs (72.76+/-9.65% for ampicillin and 85.50+/-8.35% for sulbactam). The mean peak plasma concentrations of ampicillin and sulbactam were reached at similar times (0.25+/-0.10 h and 0.24+/-0.08 h, respectively) and peak concentrations were also similar but nonproportional to the dose of both products administered (13.01+/-7.36 mg/L of ampicillin and 10.39+/-3.95 mg/L of sulbactam). Both drugs had a similar pharmacokinetic behavior after intramuscular administration in sheep. Since the plasma concentrations of sulbactam where consistently higher during the elimination phase of their disposition, consideration could be given to formulating the ampicillin-sulbactam combination in a higher than 2:1 ratio.
Similar articles
-
Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to neonatal calves.Vet J. 2005 May;169(3):437-43. doi: 10.1016/j.tvjl.2004.03.001. Vet J. 2005. PMID: 15848786 Clinical Trial.
-
Pharmacokinetics of an ampicillin/sulbactam (2:1) combination in rabbits.J Vet Pharmacol Ther. 2002 Aug;25(4):259-64. doi: 10.1046/j.1365-2885.2002.00412.x. J Vet Pharmacol Ther. 2002. PMID: 12213113
-
Comparative pharmacokinetics of an ampicillin/sulbactam combination administered intramuscularly in lactating sheep and goats.Vet Res. 1996;27(3):201-8. Vet Res. 1996. PMID: 8767882
-
The pharmacokinetics of sultamicillin.APMIS Suppl. 1989;5:17-22. APMIS Suppl. 1989. PMID: 2660866 Review.
-
[Clinical aspects of the pharmacokinetics of unasyn (an ampicillin-sulbactam combination].Antibiot Khimioter. 1992 Oct;37(10):46-51. Antibiot Khimioter. 1992. PMID: 1296537 Review. Russian. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources